We develop high-fidelity surgical simulators and advanced hydrogel biomaterials to transform surgical education, guide cancer treatment, and improve patient outcomes.
Veridien is an undergraduate-led research group at Cornell University, founded and directed by Zaid Elnasser and Hamilton Jeong, overseen by faculty advisor Prof. Suélia de Siqueira Rodrigues Fleury Rosa. We operate at the intersection of biomedical engineering, material science, and surgical education.
Our work spans two interconnected research tracks: the development of high-fidelity physical surgical simulators that give surgeons and trainees realistic, hands-on experience — and the formulation of advanced hydrogel biomaterials that faithfully replicate the mechanical properties of human tissue and organs.
We are also actively developing hydrogel-based tissue phantoms to support MRI-guided robotic interventions for cancer treatment, including brachytherapy and prostate cancer applications.
Our work bridges material science and surgical practice — from hydrogel formulation to full-system simulator development and cancer treatment guidance.
A modular, high-fidelity physical simulator designed to train surgeons in laparoscopic hysterectomy procedures. The system delivers realistic anatomical feedback, progressive difficulty, and performance assessment in a safe, controlled environment.
Mathematical and physical modeling of a triple-layer hydrogel system engineered to accurately replicate the distinct mechanical feedback of different organ types and tissue layers. This platform forms the tactile foundation of our surgical simulators.
Development of hydrogel tissue phantoms for testing and validating MRI-guided robotic needle-driven devices in two oncological contexts: interstitial brachytherapy for vaginal cancers, and targeted robotic intervention for prostate cancer treatment.
An interdisciplinary group of Cornell undergraduates working across biomedical engineering, biology, and material science.
Peer-reviewed abstracts, presentations, and publications from Veridien.
We welcome inquiries from prospective collaborators, industry partners, clinical researchers, and students interested in joining the lab.